CN113170822A - Low-fat goat milk powder for preventing and reducing hypertension, hyperglycemia and hyperlipidemia of middle-aged and elderly people and preparation method thereof - Google Patents
Low-fat goat milk powder for preventing and reducing hypertension, hyperglycemia and hyperlipidemia of middle-aged and elderly people and preparation method thereof Download PDFInfo
- Publication number
- CN113170822A CN113170822A CN202110543884.5A CN202110543884A CN113170822A CN 113170822 A CN113170822 A CN 113170822A CN 202110543884 A CN202110543884 A CN 202110543884A CN 113170822 A CN113170822 A CN 113170822A
- Authority
- CN
- China
- Prior art keywords
- powder
- vitamin
- goat milk
- fat
- preventing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 64
- 235000020251 goat milk Nutrition 0.000 title claims abstract description 22
- 235000004213 low-fat Nutrition 0.000 title claims abstract description 16
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 206010020772 Hypertension Diseases 0.000 title abstract description 14
- 201000001421 hyperglycemia Diseases 0.000 title abstract description 10
- 208000031226 Hyperlipidaemia Diseases 0.000 title abstract description 7
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims abstract description 12
- 229920001202 Inulin Polymers 0.000 claims abstract description 12
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 12
- 229940029339 inulin Drugs 0.000 claims abstract description 12
- 239000005862 Whey Substances 0.000 claims abstract description 7
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 7
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 7
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 claims abstract description 7
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 6
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 6
- 229910000019 calcium carbonate Inorganic materials 0.000 claims abstract description 6
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims abstract description 6
- 239000011790 ferrous sulphate Substances 0.000 claims abstract description 6
- 235000003891 ferrous sulphate Nutrition 0.000 claims abstract description 6
- 229910000359 iron(II) sulfate Inorganic materials 0.000 claims abstract description 6
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 6
- 229960001471 sodium selenite Drugs 0.000 claims abstract description 6
- 239000011781 sodium selenite Substances 0.000 claims abstract description 6
- 235000015921 sodium selenite Nutrition 0.000 claims abstract description 6
- 235000001855 Portulaca oleracea Nutrition 0.000 claims description 15
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 12
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 12
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 12
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 12
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 12
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 12
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 12
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 12
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 12
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 12
- 240000008042 Zea mays Species 0.000 claims description 10
- 229930003231 vitamin Natural products 0.000 claims description 10
- 235000013343 vitamin Nutrition 0.000 claims description 10
- 239000011782 vitamin Substances 0.000 claims description 10
- 229940088594 vitamin Drugs 0.000 claims description 10
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 10
- 235000010580 Psophocarpus tetragonolobus Nutrition 0.000 claims description 9
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 8
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 8
- 235000005822 corn Nutrition 0.000 claims description 8
- 241000046198 Triteleia hyacinthina Species 0.000 claims description 7
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 6
- 239000008158 vegetable oil Substances 0.000 claims description 6
- 229940075999 phytosterol ester Drugs 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 4
- 235000019498 Walnut oil Nutrition 0.000 claims description 3
- 239000003921 oil Substances 0.000 claims description 3
- 235000019198 oils Nutrition 0.000 claims description 3
- 239000008170 walnut oil Substances 0.000 claims description 3
- 240000000171 Crataegus monogyna Species 0.000 claims 1
- 244000234609 Portulaca oleracea Species 0.000 claims 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract description 10
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract description 5
- 229930003268 Vitamin C Natural products 0.000 abstract description 5
- 235000013336 milk Nutrition 0.000 abstract description 5
- 239000008267 milk Substances 0.000 abstract description 5
- 210000004080 milk Anatomy 0.000 abstract description 5
- 238000002156 mixing Methods 0.000 abstract description 5
- 230000001954 sterilising effect Effects 0.000 abstract description 5
- 235000019154 vitamin C Nutrition 0.000 abstract description 5
- 239000011718 vitamin C Substances 0.000 abstract description 5
- 238000001816 cooling Methods 0.000 abstract description 4
- 229940045997 vitamin a Drugs 0.000 abstract description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 abstract description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 abstract description 3
- 229930003316 Vitamin D Natural products 0.000 abstract description 3
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 abstract description 3
- 235000019155 vitamin A Nutrition 0.000 abstract description 3
- 239000011719 vitamin A Substances 0.000 abstract description 3
- 235000019166 vitamin D Nutrition 0.000 abstract description 3
- 239000011710 vitamin D Substances 0.000 abstract description 3
- 150000003710 vitamin D derivatives Chemical class 0.000 abstract description 3
- 229940046008 vitamin d Drugs 0.000 abstract description 3
- 229960003563 calcium carbonate Drugs 0.000 abstract description 2
- 235000010216 calcium carbonate Nutrition 0.000 abstract description 2
- 238000007599 discharging Methods 0.000 abstract description 2
- 229960001781 ferrous sulfate Drugs 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 238000004806 packaging method and process Methods 0.000 abstract description 2
- 238000007873 sieving Methods 0.000 abstract description 2
- 238000001694 spray drying Methods 0.000 abstract description 2
- 238000005507 spraying Methods 0.000 abstract description 2
- 210000000582 semen Anatomy 0.000 abstract 2
- 240000008669 Hedera helix Species 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 23
- 239000008280 blood Substances 0.000 description 23
- 230000000694 effects Effects 0.000 description 22
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 18
- 241000219304 Portulacaceae Species 0.000 description 14
- 235000019197 fats Nutrition 0.000 description 12
- 241001092040 Crataegus Species 0.000 description 11
- 230000036772 blood pressure Effects 0.000 description 9
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 7
- 235000012000 cholesterol Nutrition 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 230000004060 metabolic process Effects 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 201000001320 Atherosclerosis Diseases 0.000 description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 102000001554 Hemoglobins Human genes 0.000 description 3
- 108010054147 Hemoglobins Proteins 0.000 description 3
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 235000005686 eating Nutrition 0.000 description 3
- 201000005577 familial hyperlipidemia Diseases 0.000 description 3
- 229930003944 flavone Natural products 0.000 description 3
- 150000002212 flavone derivatives Chemical class 0.000 description 3
- 235000011949 flavones Nutrition 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 3
- 108010071619 Apolipoproteins Proteins 0.000 description 2
- 102000007592 Apolipoproteins Human genes 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 244000046095 Psophocarpus tetragonolobus Species 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 235000001465 calcium Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 239000003183 carcinogenic agent Substances 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000003467 diminishing effect Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 229940091258 selenium supplement Drugs 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 235000021391 short chain fatty acids Nutrition 0.000 description 2
- 150000004666 short chain fatty acids Chemical class 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 206010059245 Angiopathy Diseases 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 206010006956 Calcium deficiency Diseases 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 description 1
- 208000019926 Keshan disease Diseases 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000009525 Myocarditis Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010039921 Selenium deficiency Diseases 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000003217 Tetany Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 235000007244 Zea mays Nutrition 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 229940089639 cornsilk Drugs 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000006180 nutrition needs Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000013777 protein digestion Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
- 239000001231 zea mays silk Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/06—Mixtures of whey with milk products or milk components
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/04—Whey; Whey preparations containing non-milk components as source of fats or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/08—Whey; Whey preparations containing other organic additives, e.g. vegetable or animal products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/10—Whey; Whey preparations containing inorganic additives
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention relates to a low-fat goat milk powder for preventing and reducing hypertension, hyperlipidemia and hyperglycemia of middle-aged and elderly people and a preparation method thereof, wherein the production method comprises the following steps: collecting milk, storing, adding maltodextrin, calcium carbonate, ferrous sulfate, sodium selenite, desalted whey powder, inulin, herba Portulacae powder, fructus crataegi powder, semen lablab album powder, stigma Maydis powder, and semen astragali Complanati powder into fresh goat milk, preheating, adding phytosterol, mixing, and sterilizing at 120 deg.C; homogenizing at 60 deg.C and 20 Mpa; cooling at 20 deg.C, adding vitamin A, vitamin C, and vitamin D, storing, mixing, sterilizing, and vacuum concentrating; spraying under 23Mpa, spray drying, discharging, cooling, sieving, packaging, and inspecting.
Description
Technical Field
The invention relates to low-fat goat milk powder for preventing and reducing three highs of middle-aged and elderly people and a preparation method thereof, in particular to milk powder for preventing and reducing hyperlipidemia, hyperglycemia and hypertension, and belongs to the technical field of dairy processing.
Background
With the acceleration of the pace of social life and the improvement of the social living standard, the daily dietary habits of people are usually biased to high-protein, high-calorie and high-fat foods, which easily causes the symptoms of hypertension, hyperglycemia and high fat, generally called three highs. In the population, except for the more serious case requiring the cooperation of medication, most of the rest can be conditioned by diet, so that the side effect of the medication can be avoided. There are various foods for regulating "three-high" symptoms in society, but these problems are often present.
Disclosure of Invention
Aiming at the three-high symptom in the society, the inventor develops the low-fat goat milk powder for preventing and reducing the three-high symptom of the middle-aged and the old according to the nutritional needs of the body of the middle-aged and the old, and the low-fat goat milk powder has great benefits of expanding blood vessels, reducing cholesterol and blood sugar, improving the immunity of the body of the middle-aged and the old, delaying senility and prolonging the service life.
The technical scheme adopted by the invention is as follows:
the low-fat goat milk powder for preventing and reducing three highs of middle-aged and elderly people is characterized by being prepared from the following raw materials by weight:
low fat fresh goat milk 800kg of desalted whey powder 300kg based on dry weight
Maltodextrin 15kg inulin 20kg
30kg of phytosterol ester and 5kg of purslane powder
5kg of corn stigma powder and 5kg of white hyacinth bean powder
5kg of hawthorn powder and 10kg of rhizoma polygonati powder
Vitamin A450 g calcium carbonate 5500g
Vitamin C350 g sodium selenite 1300g
Vitamin D887 g ferrous sulfate 1200g
58Kg of vegetable oil.
A low-fat goat milk powder for preventing and reducing three highs of middle-aged and elderly people and a preparation method thereof are characterized in that the vegetable oil comprises:
corn germ oil 40kg walnut oil 18 kg.
Raw material analysis, raw goat milk is sweet in taste and warm in nature and enters the channels of stomach, heart and kidney; the goat milk is rich in protein, fat, carbohydrate, vitamin A, vitamin B, vitamin C, vitamin E, calcium, iron, potassium, magnesium and other nutritional ingredients, the vitamin C can promote the synthesis of collagen, enables the skin to be smooth, tender and elastic, and the magnesium is an indispensable substance for relieving pressure, can prevent the oxidation of unsaturated fatty acid in the body and delays the aging of the skin; the goat milk contains abundant nucleic acid, and can promote metabolism, reduce melanin generation, and make skin healthy, white, fine, smooth and tender. The goat milk powder is processed after defatting, and has good tasteIs light and has low fat content, and is suitable for the consumers with hypertension, hyperglycemia and hyperlipidemia. Suitable for the middle aged and the elderly, and the fat and fat-unsuitable consumers. The skim milk powder has certain benefits for middle-aged and elderly people, especially people with hypertension, hyperglycemia and hyperlipidemia. The maltodextrin is prepared with various kinds of starch as material and through enzymic process to control hydrolysis, purification and drying, and is used as stuffing and thickener for various kinds of food. The phytosterol ester is a nutrient substance extracted from plant corn or soybean, has the main effects of inhibiting the absorption of human body on cholesterol, promoting the degradation and metabolism of the cholesterol, inhibiting the synthesis of the cholesterol and the like, and has obvious curative effects on preventing and treating coronary atherosclerosis heart diseases and the like. Vitamin a has the following functions: 1. enhancing vision; 2. enhancing immunity; 3. improving the skin. Vitamin C has the following functions of preventing iron deficiency anemia; participate in the synthesis of collagen; has antioxidant effect. Vitamin D: has effects in regulating calcium and phosphorus metabolism; promoting bone growth; regulating immunity function. Calcium carbonate for the treatment and prevention of calcium deficiency disorders, such as: osteoporosis, tetany, and the like. The sodium selenite can be used for preventing and treating diseases caused by selenium deficiency, such as keshan disease and Kaschin-Beck disease, and increasing intake of microelement selenium can reduce incidence of coronary heart disease, hypertension, myocarditis, etc. Ferrous sulfate and iron are the most abundant trace elements in human body, and the iron-containing iron sulfate is used as a component of hemoglobin in red blood cells, so that the hemoglobin synthesis capability of the red blood cells is reduced and the amount of hemoglobin is reduced in the absence of iron. The desalted whey powder is a powdery product prepared by dehydration and desalting, and the full cream milk powder is a powdery product prepared by taking cow milk or goat milk as a raw material and concentrating and drying, and has the advantages of high fat content, high nutritive value, more comprehensive nutritive value and better taste. Inulin, which can improve hyperlipemia, can generate a large amount of short-chain fatty acids in the fermentation process of prebiotics and bacteria in intestinal tracts, the short-chain fatty acids can help people to improve blood fat and promote metabolism of human bodies, the inulin can promote the growth of bifidobacteria in the intestinal tracts, and the aim of improving the environment of the intestinal tracts is fulfilled by reducing the level of the bifidobacteria, so that the inulin can improve the hyperlipemiaThe inulin has certain auxiliary effect on people with constipation, has the effect of controlling blood fat, and can effectively reduce serum total cholesterol and low density protein cholesterol, increase high density lipoprotein and improve the blood fat condition by taking the inulin. It can lower blood sugar, inulin is a carbohydrate which does not cause elevation of glucose in urine, and it is not hydrolyzed into monosaccharide in the upper part of intestinal tract, thus not raising blood sugar level and insulin content; the purslane powder and the purslane have rich nutrition and are known as 'vegetable vitamin pills', and the purslane powder and the purslane have the following effects:
the purslane is rich in selenium which can inhibit liver cancer, skin cancer and lymph cancer induced by chemical carcinogens; the vitamin E can reduce carcinogenesis of carcinogenic agent, and protect cell injury and canceration induced by radioactive element.
Sterilizing and diminishing inflammation: the purslane has the effects of clearing away damp-heat, stopping dysentery and diminishing inflammation, and has strong inhibition effect on various bacteria such as dysentery bacillus, colon bacillus and the like; there is a name of "natural antibiotics".
Reducing blood pressure: the purslane contains various potassium salts and has certain antihypertensive effect due to high-potassium diet, and potassium ions can directly act on angiopathy and effectively protect the blood vessels from being damaged. Therefore, the incidence of hypertension and apoplexy can be reduced by eating more purslane.
Beneficial to cardiovascular and cerebrovascular health: the carotene contained in the purslane has the functions of delaying senility and preventing cardiovascular and cerebrovascular diseases; also contains some bioactive substances, and the bioactive substances have good prevention and treatment effects on cardiovascular diseases such as heart disease, hypertension, apoplexy, diabetes and the like. Corn silk powder: has effects of improving hypertension, hyperlipemia and hyperglycemia, and has effects of lowering bloodHas lipid effect, and is effective in protecting heart and brain, reducing blood sugar, relieving physical and mental stress, promoting blood circulation, and preventing hypertension. White hyacinth bean powder: the hyacinth bean has the functions of reducing blood sugar, is one of the important functions of the hyacinth bean, contains amylase, can inhibit the absorption of a human body to sugar, can also accelerate the metabolism and decomposition of the sugar in the body, can reduce overhigh blood sugar, and can improve the pancreatic island function of the human body; promote the secretion of insulin, which is also the important reason that white hyacinth bean can reduce blood sugar. The hawthorn powder has the effects of reducing blood fat, reducing blood pressure, strengthening heart, resisting arrhythmia and the like, and is a food material for tonifying spleen, stimulating appetite, promoting digestion, removing food stagnation, promoting blood circulation and removing blood stasis. 1. Has digestion promoting effect, and the hawthorn contains various organic acids, can enhance gastric acidity, improve pepsin activity and promote protein digestion after being orally taken, and contains lipase which can promote fat digestion. 2. Reducing blood lipid, and resisting atherosclerosis, wherein the hawthorn flavone can significantly reduce the concentrations of serum total cholesterol, low-density lipoprotein cholesterol and apolipoprotein of experimental hyperlipidemic animals, and significantly increase the concentrations of the high-density lipoprotein cholesterol and apolipoprotein, but has little influence on triglyceride. The hawthorn has the function of reducing blood fat by inhibiting the synthesis of liver cholesterol and promoting the intake of plasma cholesterol by the liver. The hawthorn flavone can also reduce the risk of atherosclerosis, and has the function of preventing the development of atherosclerosis. The hawthorn also has the function of reducing blood pressure, and hawthorn flavone has a certain function of reducing blood pressure after being administrated in veins, abdominal cavities and duodenum, and the function mechanism is mainly related to the function of expanding peripheral blood vessels. Rhizoma polygonati powder has the functions of tonifying qi and yin, strengthening the spleen, moistening the lung and tonifying the kidney, is used for treating symptoms such as weakness of the spleen and the stomach, tiredness and hypodynamia, dry mouth and poor appetite, lung deficiency and dry cough, insufficiency of essence and blood, internal heat and diabetes, and has obvious curative effect on treating diabetes. Modern medical research shows that rhizoma polygonati also has the effects of reducing blood pressure, blood sugar and blood fat, preventing atherosclerosis, delaying senility and resisting bacteria.
Compared with the prior art, the invention has the following beneficial effects:
(1) according to the invention, by adding inulin, purslane powder, hawthorn powder, white hyacinth bean powder, corn stigma powder and sealwort powder which are homologous in medicine and food, the effects of reducing blood pressure, blood fat and blood sugar can be exerted on the aspect of preventing three-high symptoms of middle-aged and elderly people. The invention fills in a gap in the dairy product industry, can control blood fat, reduce blood sugar and reduce blood pressure, and has the great characteristic that the human body becomes healthier by eating the milk powder for a long time.
(2) The purslane powder and the rhizoma polygonati powder are added, so that the immunity of middle-aged and elderly people can be enhanced, and the effects of delaying senility and prolonging the life are achieved.
Detailed Description
Low fat fresh goat milk 800kg of desalted whey powder 300kg based on dry weight
Maltodextrin 15kg inulin 20kg
30kg of phytosterol ester and 5kg of purslane powder
5kg of corn stigma powder and 5kg of white hyacinth bean powder
5kg of hawthorn powder and 10kg of rhizoma polygonati powder
Vitamin A450 g calcium carbonate 5500g
Vitamin C350 g sodium selenite 1300g
Vitamin D887 g ferrous sulfate 1200g
58Kg of vegetable oil.
A low-fat goat milk powder for preventing and reducing three highs of middle-aged and elderly people and a preparation method thereof are characterized in that the vegetable oil comprises:
corn germ oil 40kg walnut oil 18 kg.
A low-fat goat milk powder for preventing and reducing three highs of middle-aged and elderly people is characterized in that the production method comprises the following steps: the method comprises the steps of collecting milk, storing, mixing, adding desalted whey powder, maltodextrin, calcium carbonate, ferrous sulfate, sodium selenite, desalted whey powder, inulin, purslane powder, hawthorn powder, white hyacinth bean powder, corn stigma powder and sealwort powder into fresh goat milk, preheating, adding phytosterol ester, mixing, sterilizing at 120 ℃, homogenizing at 60 ℃ and 20Mpa, cooling at 20 ℃, adding vitamin A, vitamin C and vitamin D, storing and mixing materials, sterilizing, vacuum concentrating, spraying at 23Mpa, spray drying, discharging powder, cooling, sieving, packaging, inspecting and obtaining the finished product.
By trial of 100 cases of patients with hyperlipidemia, hyperglycemia and hypertension, the milk powder is taken three times a day, 30g each time, with warm boiled water for oral administration when the people are between 40 and 65 years old.
And (4) trial results:
effect example 1:
after a woman with hypertension eats the preparation for 3 months, the weight of the woman loses 10 jin, the blood pressure is reduced from 160/95mmHg to 145/85mmHg, the blood pressure is reduced to 127/86mmHg after the patient continues to eat the preparation for 3 months, and other indexes are recovered to be normal.
Effect example 2:
after a male and a hyperlipemia patient eat the preparation for 3 months, the weight is reduced by 15 jin, the triglyceride is reduced to 7.42mmol/L from the original 8.92mmol/L, and after the preparation is eaten for 3 months, the previous standard exceeding numerical values are all restored to normal numerical values.
Effect example 3:
zhao, women, having hyperglycemia, after eating the preparation of the invention continuously for 2 months, the weight is reduced by 13 jin, the blood sugar is reduced from the original 11.4mmol/L to 5.3mmol/L, and the blood sugar index is recovered to the normal value.
In view of the above, the present invention is a specific embodiment, but the scope of protection is not limited thereto, and any person skilled in the art should be within the scope of protection of the present invention by substituting equivalent alternatives according to the technical solutions and concepts of the present invention in the technical fields described in the present invention.
Claims (2)
1. The low-fat goat milk powder for preventing and reducing three highs of middle-aged and elderly people and the preparation method thereof are characterized by being prepared from the following raw materials by weight:
low fat fresh goat milk 800kg of desalted whey powder 300kg based on dry weight
Maltodextrin 15kg inulin 20kg
30kg of phytosterol ester and 5kg of purslane powder
5kg of corn stigma powder and 5kg of white hyacinth bean powder
5kg of hawthorn powder and 10kg of rhizoma polygonati powder
Vitamin A450 g calcium carbonate 5500g
Vitamin C350 g sodium selenite 1300g
Vitamin D887 g ferrous sulfate 1200g
58Kg of vegetable oil.
2. The low-fat goat milk powder for preventing and reducing three highs of middle-aged and elderly people and the preparation method thereof as claimed in claim 1, wherein the vegetable oil comprises:
corn germ oil 40kg walnut oil 18 kg.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110543884.5A CN113170822A (en) | 2021-05-19 | 2021-05-19 | Low-fat goat milk powder for preventing and reducing hypertension, hyperglycemia and hyperlipidemia of middle-aged and elderly people and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110543884.5A CN113170822A (en) | 2021-05-19 | 2021-05-19 | Low-fat goat milk powder for preventing and reducing hypertension, hyperglycemia and hyperlipidemia of middle-aged and elderly people and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113170822A true CN113170822A (en) | 2021-07-27 |
Family
ID=76929579
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110543884.5A Pending CN113170822A (en) | 2021-05-19 | 2021-05-19 | Low-fat goat milk powder for preventing and reducing hypertension, hyperglycemia and hyperlipidemia of middle-aged and elderly people and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113170822A (en) |
Citations (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104054826A (en) * | 2014-06-26 | 2014-09-24 | 江西雄鹰乳业有限公司 | Milk powder capable of preventing and lowering hyperlipidemia, hyperglycemia and hypertension |
| CN106578078A (en) * | 2016-12-07 | 2017-04-26 | 南京苏新智慧社区服务有限公司 | Efficient-absorption oligopeptide formula goat milk powder and preparation method thereof |
| CN107751387A (en) * | 2017-10-28 | 2018-03-06 | 卜球 | A kind of formula milk and its production method for helping to reduce blood sugar for human body |
| CN107771946A (en) * | 2017-10-28 | 2018-03-09 | 卜球 | A kind of formula milk and its production method for contributing to middle-aged and old cardiovascular and cerebrovascular health |
| CN108576230A (en) * | 2018-05-09 | 2018-09-28 | 深圳市鑫永康生物技术开发有限公司 | The formula and preparation method of a kind of auxiliary adjustment blood glucose, blood fat milk powder |
| CN108902324A (en) * | 2018-06-28 | 2018-11-30 | 陕西秦王乳业有限公司 | A kind of person in middle and old age's high-calcium milk powder and preparation method thereof |
| CN109662151A (en) * | 2018-12-26 | 2019-04-23 | 光明乳业股份有限公司 | A kind of person in middle and old age's milk powder and preparation method thereof |
| CN111602720A (en) * | 2020-05-11 | 2020-09-01 | 呼伦贝尔双娃乳业有限公司 | Formula milk powder for middle-aged and old people |
| CN111771988A (en) * | 2020-07-23 | 2020-10-16 | 江西人之初乳品营养有限公司 | Nutritional food suitable for diabetic patients and preparation method thereof |
| CN112106836A (en) * | 2020-09-29 | 2020-12-22 | 西藏高原之宝牦牛乳业股份有限公司 | Yak milk powder for middle-aged and old people and preparation method thereof |
| CN112189711A (en) * | 2020-10-30 | 2021-01-08 | 广州市美素力营养品有限公司 | Milk powder for assisting in reducing hypertension, hyperglycemia and hyperlipidemia of middle-aged and old people |
| CN112205479A (en) * | 2020-10-10 | 2021-01-12 | 齐齐哈尔盛世云鹤信息技术集团有限公司 | Formula milk powder for middle-aged and old people and preparation method thereof |
| CN112602781A (en) * | 2020-12-26 | 2021-04-06 | 四川金汇源农业科技有限责任公司 | Formula of milk powder helpful for reducing and preventing three highs and preparation method thereof |
| CN112655765A (en) * | 2020-12-09 | 2021-04-16 | 魏利成 | Milk powder formula capable of delaying aging and preventing cardiovascular and cerebrovascular diseases and diabetes |
-
2021
- 2021-05-19 CN CN202110543884.5A patent/CN113170822A/en active Pending
Patent Citations (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104054826A (en) * | 2014-06-26 | 2014-09-24 | 江西雄鹰乳业有限公司 | Milk powder capable of preventing and lowering hyperlipidemia, hyperglycemia and hypertension |
| CN106578078A (en) * | 2016-12-07 | 2017-04-26 | 南京苏新智慧社区服务有限公司 | Efficient-absorption oligopeptide formula goat milk powder and preparation method thereof |
| CN107751387A (en) * | 2017-10-28 | 2018-03-06 | 卜球 | A kind of formula milk and its production method for helping to reduce blood sugar for human body |
| CN107771946A (en) * | 2017-10-28 | 2018-03-09 | 卜球 | A kind of formula milk and its production method for contributing to middle-aged and old cardiovascular and cerebrovascular health |
| CN108576230A (en) * | 2018-05-09 | 2018-09-28 | 深圳市鑫永康生物技术开发有限公司 | The formula and preparation method of a kind of auxiliary adjustment blood glucose, blood fat milk powder |
| CN108902324A (en) * | 2018-06-28 | 2018-11-30 | 陕西秦王乳业有限公司 | A kind of person in middle and old age's high-calcium milk powder and preparation method thereof |
| CN109662151A (en) * | 2018-12-26 | 2019-04-23 | 光明乳业股份有限公司 | A kind of person in middle and old age's milk powder and preparation method thereof |
| CN111602720A (en) * | 2020-05-11 | 2020-09-01 | 呼伦贝尔双娃乳业有限公司 | Formula milk powder for middle-aged and old people |
| CN111771988A (en) * | 2020-07-23 | 2020-10-16 | 江西人之初乳品营养有限公司 | Nutritional food suitable for diabetic patients and preparation method thereof |
| CN112106836A (en) * | 2020-09-29 | 2020-12-22 | 西藏高原之宝牦牛乳业股份有限公司 | Yak milk powder for middle-aged and old people and preparation method thereof |
| CN112205479A (en) * | 2020-10-10 | 2021-01-12 | 齐齐哈尔盛世云鹤信息技术集团有限公司 | Formula milk powder for middle-aged and old people and preparation method thereof |
| CN112189711A (en) * | 2020-10-30 | 2021-01-08 | 广州市美素力营养品有限公司 | Milk powder for assisting in reducing hypertension, hyperglycemia and hyperlipidemia of middle-aged and old people |
| CN112655765A (en) * | 2020-12-09 | 2021-04-16 | 魏利成 | Milk powder formula capable of delaying aging and preventing cardiovascular and cerebrovascular diseases and diabetes |
| CN112602781A (en) * | 2020-12-26 | 2021-04-06 | 四川金汇源农业科技有限责任公司 | Formula of milk powder helpful for reducing and preventing three highs and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101530195B (en) | Food formula of special diet containing oligopeptides for maternity patient | |
| CN110338402A (en) | A kind of compound probiotic powder and preparation method thereof | |
| CN105815514A (en) | Weight-losing quinoa milk tea | |
| CN106418501A (en) | Healthcare food with weight reducing function | |
| CN104824674A (en) | Nutrient health-care food for preventing and treating alopecia | |
| CN104839695A (en) | Inflammatory bowel disease non-total nutrient formula food | |
| CN104323391A (en) | Plant health solid drink and preparation method thereof | |
| CN1685885A (en) | Preparation method of sour soymilk containing mulberry leaves, hawthorn etc. for lowering sugar, aid sleeping, boost intestine | |
| CN109043555A (en) | A kind of Special food and preparation method thereof that hyperglycemic patients are edible | |
| CN115553406A (en) | Weight-reducing composition beverage for inhibiting absorption of fat and sugar substances and preparation method thereof | |
| CN113170822A (en) | Low-fat goat milk powder for preventing and reducing hypertension, hyperglycemia and hyperlipidemia of middle-aged and elderly people and preparation method thereof | |
| CN113749152A (en) | Health preserving and body building drink and preparation method thereof | |
| CN100387153C (en) | Method for preparing blood sugar-decreasing, stomach-benefiting, health-preserving soybean yoghurt with micron holoside, ginseng, solomonseal, chlorophyll, propolis and chromium powder | |
| CN109090621A (en) | A kind of Special food and preparation method thereof that constipation crowd eats | |
| CN1792188A (en) | Method for preparing soymilk powder contg. micron additives for tonifying-Yin and eliminating-fatigue | |
| CN110089754A (en) | Liver and gallbladder health care product | |
| CN104187264B (en) | A kind of alimentation composition that improves body immunity and preparation method thereof | |
| CN106805094A (en) | A kind of cereal health preserving dietotherapy composition and preparation method thereof | |
| CN1799381A (en) | Method for preparing yin-nourishing health-preserving soybean with oligosaccharide and micron powder of American ginseng, dried solomonseal, tortoise plastron, dendrobium stem and siberian solomonseal | |
| CN100340179C (en) | Method for preparing blood sugar-decreasing, stomach-benefiting, health-preserving soybean milk powder with micron holoside, ginseng, solomonseal, chlorophyll, propolis and chromium powder | |
| CN117297081A (en) | Dampness-dispelling spleen-strengthening beauty-maintaining powder and preparation method thereof | |
| CN100340177C (en) | Method for preparing blood sugar-decreasing, stomach-benefiting, health-preserving soybean milk tablet with micron holoside, ginseng, solomonseal, chlorophyll, propolis and chromium powder | |
| CN1792185A (en) | Method for preparing soymilk powder contg. micron additives for tonifying-Yin and nourishing of life | |
| CN1328979C (en) | Method for preparing soymilk tablets contg micron sugared ginseng and bee-glue etc. for tonifying-Yin and nourishing-stomach | |
| CN115039873A (en) | Superfine brewing powder for regulating spleen and stomach, and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20210727 |